Friday, September 6, 2013

Oncothyreon Names New Board Member

Seattle-based Oncothyreon announced this morning that it has bolstered its board of directors. The biopharmaceuticals firm said it has added Ted W. Love, M.D., ot its board. Love was previously Executive Vice President and Head of Research and Development and Technical Operations at Onyx Pharmaceuticals, and also has served at Nuvelo, Theravance, and Genentech. Love also has served on the boards of Santarus, Amicus, and Kalobios.